1	.	.	Fp	-	-	0-1	589_QUEST_clinical_caseMIR	SENT1	-	-

1	Cuál	cuál	PT0CS000	-	-	2-6	589_QUEST_clinical_caseMIR	SENT2	-	-
2	es	ser	VSIP3S0	-	-	7-9	589_QUEST_clinical_caseMIR	SENT2	-	-
3	el	el	DA0MS0	-	-	10-12	589_QUEST_clinical_caseMIR	SENT2	-	-
4	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	13-24	589_QUEST_clinical_caseMIR	SENT2	-	-
5	más	más	RG	C0205172	calificador	25-28	589_QUEST_clinical_caseMIR	SENT2	-	-
6	probable	probable	AQ0CS0	C0332148	calificador	29-37	589_QUEST_clinical_caseMIR	SENT2	-	-
7	de	de	SPS00	C0332285	atributo	38-40	589_QUEST_clinical_caseMIR	SENT2	-	-
8	un	un		C0205447_1	calificador_1	41-43	589_QUEST_clinical_caseMIR	SENT2	-	-
9	paciente	paciente	NCCS000	C0030705	persona	44-52	589_QUEST_clinical_caseMIR	SENT2	-	-
10	con	con	SPS00	C0332287	atributo	53-56	589_QUEST_clinical_caseMIR	SENT2	-	-
11	trombopenia	trombopenia	NCFS000	C0040034_1	trastorno_1	57-68	589_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
12	progresiva	progresivo	AQ0FS0	C0205329	calificador	69-79	589_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
13	,	,	Fc	-	-	79-80	589_QUEST_clinical_caseMIR	SENT2	-	-
14	niveles	nivel	NCMP000	C0456079	atributo	81-88	589_QUEST_clinical_caseMIR	SENT2	-	-
15	de	de	SPS00	C0332285	atributo	89-91	589_QUEST_clinical_caseMIR	SENT2	-	-
16	fibrinogeno	fibrinogeno	NCMS000	-	-	92-103	589_QUEST_clinical_caseMIR	SENT2	-	-
17	bajos	bajo	AQ0MP0	C0205251	calificador	104-109	589_QUEST_clinical_caseMIR	SENT2	-	-
18	,	,	Fc	-	-	109-110	589_QUEST_clinical_caseMIR	SENT2	-	-
19	alargamiento	alargamiento	NCMS000	C0441592	calificador	111-123	589_QUEST_clinical_caseMIR	SENT2	-	-
20	de	de	SPS00	C0332285	atributo	124-126	589_QUEST_clinical_caseMIR	SENT2	-	-
21	los	el	DA0MP0	-	-	127-130	589_QUEST_clinical_caseMIR	SENT2	-	-
22	tiempos	tiempo	NCMP000	C0040223#C3541383	calificador#atributo#metadato_fundacional	131-138	589_QUEST_clinical_caseMIR	SENT2	-	-
23	de	de	SPS00	C0332285	atributo	139-141	589_QUEST_clinical_caseMIR	SENT2	-	-
24	protrombina	protrombina	NCFS000	C0033706	sustancia	142-153	589_QUEST_clinical_caseMIR	SENT2	-	-
25	y	y	CC	C1706368	calificador	154-155	589_QUEST_clinical_caseMIR	SENT2	-	-
26	tromboplastina	tromboplastina	NCFS000	C0040048	producto#sustancia	156-170	589_QUEST_clinical_caseMIR	SENT2	-	-
27	parcial	parcial	AQ0CS0	C0728938#C0205257#C0728939	calificador	171-178	589_QUEST_clinical_caseMIR	SENT2	-	-
28	activada	activar	VMP00SF	-	-	179-187	589_QUEST_clinical_caseMIR	SENT2	-	-
29	,	,	Fc	-	-	187-188	589_QUEST_clinical_caseMIR	SENT2	-	-
30	aumento	aumento	NCMS000	C0442805	calificador	189-196	589_QUEST_clinical_caseMIR	SENT2	-	-
31	de	de	SPS00	C0332285	atributo	197-199	589_QUEST_clinical_caseMIR	SENT2	-	-
32	los	el	DA0MP0	-	-	200-203	589_QUEST_clinical_caseMIR	SENT2	-	-
33	dímeros-D	dímeros-d	NCFS000	-	-	204-213	589_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
34	y	y	CC	C1706368	calificador	214-215	589_QUEST_clinical_caseMIR	SENT2	-	-
35	esquistocitos	esquistocito	NCMP000	C0221282	célula	216-229	589_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
36	en	en	SPS00	C1720294#C0332285	calificador#atributo	230-232	589_QUEST_clinical_caseMIR	SENT2	-	-
37	el	el	DA0MS0	-	-	233-235	589_QUEST_clinical_caseMIR	SENT2	-	-
38	frotis	frotis	NCMN000	-	-	236-242	589_QUEST_clinical_caseMIR	SENT2	-	-
39	de	de	SPS00	C0332285	atributo	243-245	589_QUEST_clinical_caseMIR	SENT2	-	-
40	sangre	sangre	NCFS000	C0229664_1	sustancia_1	246-252	589_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
41	periférica	periférico	AQ0FS0	C0229664_2	sustancia_2	253-263	589_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
42	.	.	Fp	-	-	263-264	589_QUEST_clinical_caseMIR	SENT2	-	-

